Clinical value of gugua extract injection in patients with limb fracture after operation
-
Last Update: 2014-09-29
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Recently, researchers from the 425 Hospital of PLA published a paper to explore the clinical value of gugua extract injection in patients with limb fracture after operation The study points out that the intravenous application of gugua extract injection can significantly accelerate the regression of local pain and swelling, shorten the time of fracture healing, facilitate the recovery of limb function, and reduce the incidence of postoperative infection, with good safety and satisfactory clinical effect This article was published in the 25th issue of the Journal of modern integrated Chinese and Western medicine in 2014 153 patients with limb fracture undergoing selective operation were randomly divided into treatment group (77 cases) and control group (76 cases) All patients were treated with open reduction and internal fixation, and were given routine symptomatic, anti infection treatment and limb function exercise guidance On this basis, the treatment group was added with bone melon extract injection, while the control group was not added with any drugs to promote fracture healing The degree of pain and swelling, healing time, functional recovery and adverse reactions were compared before and after treatment After 3 days of treatment, the VAS score of the treatment group was significantly lower than that of the control group (P < 0.01); 7 After D, the swelling disappearance rate of the treatment group was significantly higher than that of the control group (P < 0.01); the healing time of each fracture site of upper limb bone and lower limb bone in the treatment group was significantly shorter than that of the control group (P < 0.01); the excellent rate and total effective rate of functional recovery were also significantly higher than that of the control group (P < 0.01); no drug-related adverse reactions were found in both groups, and the incidence of postoperative infection in the treatment group was significantly lower than that of the control group (P < 0.01) 05).
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.